Question 1

What is Quillivant XR?

Accepted Answer

Quillivant XR is a central nervous system stimulant that contains the active ingredient methylphenidate hydrochloride. It is an extended-release formulation designed to provide a steady release of medication into the system over a period of time.

This medication works by influencing the activity of certain natural chemicals in the brain. It is used to help manage and balance these substances to affect behavioral and cognitive functions.

Question 2

What is Quillivant XR used for?

Accepted Answer

Quillivant XR is used to treat attention deficit hyperactivity disorder .

Question 3

How does Quillivant XR work?

Accepted Answer

Mechanism of Action

Quillivant XR belongs to a class of medications called central nervous system stimulants. While the exact way it works to treat Attention Deficit Hyperactivity Disorder (ADHD) is not fully understood, it is believed to change the balance of certain natural substances in the brain.

The medication primarily affects two chemicals called neurotransmitters:

Dopamine: This chemical is involved in motivation, reward, and movement.

Norepinephrine: This chemical helps the brain focus and respond to stimuli.

Quillivant XR works by blocking these chemicals from being reabsorbed by the nerve cells in the brain. By keeping more dopamine and norepinephrine available in the spaces between nerve cells, the medication helps improve focus and concentration while reducing impulsive behavior and hyperactivity.

Because this is an extended-release liquid formulation, the medication is designed to release the active ingredient slowly into the body. This allows for a steady effect over a longer period of time compared to immediate-release versions of the medication.

Question 4

What are the active ingredients in Quillivant XR?

Accepted Answer

The active ingredient in Quillivant XR is methylphenidate .

Question 5

What are the side effects of Quillivant XR?

Accepted Answer

Common side effects of Quillivant XR may include:

loss of appetite

insomnia

headache

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Quillivant XR?

Accepted Answer

Quillivant XR belongs to the stimulant drug class .

Question 7

What is the dosage of Quillivant XR and how do I take it?

Accepted Answer

How to Take Quillivant XR

Quillivant XR is a liquid suspension that is usually taken once a day in the morning. It can be taken with or without food, but it is important to be consistent with how you take it each day.

Before each dose, shake the bottle vigorously for at least 10 seconds. This ensures the medication is evenly distributed throughout the liquid. Use only the oral dosing dispenser that comes with the medication to measure your dose. Do not use a kitchen spoon or other measuring devices, as they may not provide the correct amount.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is late in the day, it may be best to skip the missed dose to avoid trouble sleeping at night. Do not take two doses at once to make up for a missed one.

Question 8

Is Quillivant XR safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of Quillivant XR in pregnant women. Healthcare providers generally recommend using this medication during pregnancy only if the potential benefit to the mother outweighs the potential risk to the developing fetus. Some studies have investigated whether methylphenidate increases the risk of heart-related birth defects, but the evidence remains limited and inconclusive.

Individuals who are pregnant or planning to become pregnant should consult their healthcare provider to discuss the risks and benefits of continuing treatment. There is a pregnancy registry that monitors outcomes for people who take ADHD medications during pregnancy to help researchers better understand any potential risks.

Breastfeeding

Methylphenidate, the active ingredient in Quillivant XR, is known to pass into breast milk. It is important to discuss the risks and benefits of breastfeeding while taking this medication with a healthcare professional. If a mother chooses to breastfeed while taking Quillivant XR, the infant should be closely monitored for potential side effects, such as:

Agitation or irritability

Difficulty sleeping

Poor weight gain or feeding problems

A healthcare provider can help determine whether to continue breastfeeding or adjust the medication based on the needs of both the mother and the infant.

Question 9

What forms and strengths does Quillivant XR come in?

Accepted Answer

Quillivant XR is provided in the following form:

Extended-release oral suspension: This medication is supplied as a powder. A pharmacist adds water to the powder to create a liquid suspension before it is dispensed to the patient.

The extended-release liquid is designed to release the medication over a prolonged period after ingestion.

Question 10

What is the FDA approval status of Quillivant XR?

Accepted Answer

FDA Approval and Indication

Quillivant XR was approved by the U.S. Food and Drug Administration (FDA) in September 2012. It is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. It was the first liquid extended-release methylphenidate formulation to receive FDA approval for this condition.

Boxed Warning

The FDA requires a Boxed Warning for Quillivant XR because methylphenidate has a high potential for abuse and dependence. Healthcare providers are instructed to assess the risk of abuse before prescribing the medication and to monitor patients for signs of misuse and dependence during treatment.

Controlled Substance Status

Quillivant XR is classified as a Schedule II (CII) controlled substance by the Drug Enforcement Administration (DEA). This classification is due to the medication's high potential for abuse, which may lead to severe psychological or physical dependence. Because of this status, there are strict regulatory requirements for prescribing and dispensing the drug, including limitations on refills.

Pediatric Safety Monitoring

The FDA conducts ongoing safety reviews of methylphenidate products, including pediatric safety reviews presented to advisory committees. These reviews monitor for potential adverse events such as cardiovascular issues and psychiatric symptoms to ensure the continued safety of the medication in children and adolescents.

Question 11

What should I know about Quillivant XR and weight loss?

Accepted Answer

Appetite and Weight Changes

Weight loss is a frequently reported side effect for individuals taking Quillivant XR. This occurs primarily because the medication can significantly decrease appetite, leading to lower caloric intake.

Impact on Children and Adolescents

In pediatric patients, the use of stimulants like Quillivant XR may be associated with a temporary slowing in growth rate, including both weight gain and height. Because of this, doctors usually perform the following checks during treatment:

Regularly monitoring weight and height.

Assessing growth patterns against standard charts.

Adjusting the treatment plan if growth or weight gain is not as expected.

Managing Weight Loss

If weight loss becomes a concern, a healthcare provider may suggest strategies to ensure adequate nutrition. These might include:

Eating larger meals at times when the medication effects are lower, such as breakfast before the morning dose or a late evening snack.

Choosing nutrient-dense foods.

Discussing the possibility of a treatment break under medical supervision if growth is significantly impacted.

It is important to contact a healthcare provider if weight loss is significant or if a child does not seem to be growing or gaining weight at a normal rate while taking this medication.

Quillivant XR

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Weight Loss Information

FAQ

Found an Error?